Search and analyze individual stocks with comprehensive metrics
Hemadri Cements Ltd
Fundamental Score
Hemadri Cements Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of HEMACEM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (35.59%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Balanced Promoter Holding (66.31%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
11 factors identified
Below-Average Return on Equity (-281.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-77.44%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (-13.82%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Limited Growth History (-35.30% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Interest Coverage (-7.40x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-11.87 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Loading Peer Comparison
Finding companies in the Cement & Cement Products sector...
Financial Statements
Comprehensive financial data for Hemadri Cements Ltd
About HEMACEM
Business Overview
Hemadri Cements Limited engages in the production and sale of cement and clinker in India. The company was incorporated in 1981 and is based in Chennai, India.
Company Details
Key Leadership
HEMACEM Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Hemadri Cements Ltd (HEMACEM)?
As of 02 Jan 2026, 04:27 pm IST, Hemadri Cements Ltd (HEMACEM) is currently trading at ₹50.88. The stock has a market capitalization of ₹33.94 (Cr).
Is HEMACEM share price Overvalued or Undervalued?
HEMACEM is currently trading at a P/E ratio of 0.00x, compared to the industry average of 33.70x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Hemadri Cements Ltd share price?
Key factors influencing HEMACEM's price include its quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Hemadri Cements Ltd a good stock for long-term investment?
Hemadri Cements Ltd shows a 5-year Profit Growth of N/A% and an ROE of -281.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing.
How does Hemadri Cements Ltd compare with its industry peers?
Hemadri Cements Ltd competes with major peers in the Cement & Cement Products. Investors should compare HEMACEM's P/E of 0.00x and ROE of -281.44% against the industry averages to determine its competitive standing.
What is the P/E ratio of HEMACEM and what does it mean?
HEMACEM has a P/E ratio of N/Ax compared to the industry average of 33.70x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is HEMACEM performing according to Bull Run's analysis?
HEMACEM has a Bull Run fundamental score of 18/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does HEMACEM belong to?
HEMACEM operates in the Cement & Cement Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Hemadri Cements Ltd.
What is Return on Equity (ROE) and why is it important for HEMACEM?
HEMACEM has an ROE of -281.44%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Hemadri Cements Ltd generates profits from shareholders' equity.
How is HEMACEM's debt-to-equity ratio and what does it indicate?
HEMACEM has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is HEMACEM's dividend yield and is it a good dividend stock?
HEMACEM offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has HEMACEM grown over the past 5 years?
HEMACEM has achieved 5-year growth rates of: Sales Growth -35.30%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in HEMACEM and why does it matter?
Promoters hold 66.31% of HEMACEM shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is HEMACEM's market capitalization category?
HEMACEM has a market capitalization of ₹34 crores, placing it in the Small-cap category.
How volatile is HEMACEM stock?
HEMACEM has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for HEMACEM?
HEMACEM has a 52-week high of ₹N/A and low of ₹N/A.
What is HEMACEM's operating profit margin trend?
HEMACEM has a 5-year average Operating Profit Margin (OPM) of -13.82%, indicating the company's operational efficiency.
How is HEMACEM's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -100.00% and YoY Profit Growth of 35.59%.
What is the institutional holding pattern in HEMACEM?
HEMACEM has FII holding of 0.00% and DII holding of 0.01%. Significant institutional holding often suggests professional confidence in the stock.